Walk With Us! Be Proactive!
There is strength in numbers and our team hopes you will join us in the fight against Parkinson's disease (PD) by donating today for the APDA Walk for Optimism, and also learning about the Yale KET-PD Trial. CureNow and Yale KET-PD are teaming up to Walk and we want you to join us!! Plus, CureNow wants to share some important information about the Yale PD KET Trial:
In this Michael J Fox Foundation-funded clinical trial, they will examine the efficacy of ketamine in treating depression in Parkinson’s disease for the first time. They are looking for volunteers with Parkinson’s disease and symptoms of depression (age 40-80).
Depression affects around half of people with Parkinson’s disease and significantly adds to the burden of the disease. However, existing antidepressants are not effective in treating depression in Parkinson’s disease and new treatments are urgently needed. Ketamine is a drug that has been traditionally used as an anesthetic, but is now being used as an antidepressant, based on the discovery that it rapidly reduces symptoms of depression. Ketamine holds significant potential for effectively treating depression in Parkinson’s disease. They will test this for the first time in a controlled, clinical trial. They will also use brain imaging to determine how it works in the brain.
The trial will involve coming to Yale for a total of 9 visits, in which you will receive 6 infusions of either ketamine or placebo (administered twice per week for 3 weeks). You will also have the option to take part in brain imaging before and after treatment, which will help them determine its effects on the brain.
You will be reimbursed up to $2000 for your participation in this trial, and taking part could help with the discovery of important new treatments for depression in Parkinson’s disease.
Learn more HERE